Skip to main content
Figure 5 | BMC Neurology

Figure 5

From: Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties

Figure 5

Changes in IL-17 serum levels after 3 months supplementation with vitamin D. A significant increase in serum IL-17 was detected at 3 month in the low dose vitamin D group (p = 0.037). Serum IL-17 response to high dose vitamin D was heterogeneous. 3 patients in each dosage group had IL-17 levels below the detection threshold of the ELISA kit at both time points (not shown in the figure).

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us